Warrant (finance)

Vivos Therapeutics Announces Pricing of $4 Million Private Placement Priced At-the-Market Under Nasdaq Rules

Retrieved on: 
Tuesday, October 31, 2023
Sale, OSA, Prospectus, Warrant (finance), Vivos, Snoring, Therapy, Patient, Security (finance)

The Series A and Series B Warrants will have an exercise price of $3.83 per share and will be exercisable immediately following the date of issuance.

Key Points: 
  • The Series A and Series B Warrants will have an exercise price of $3.83 per share and will be exercisable immediately following the date of issuance.
  • The closing of the private placement is expected to occur on or about November 2, 2023, subject to the satisfaction of customary closing conditions.
  • The gross proceeds from the offering are expected to be approximately $4.0 million.
  • Any offering of the securities under the resale registration statement will only be by means of a prospectus.

Top Strike Announces 2024 First Quarter Financial Results ending July 31, 2023 and Corporate Update

Retrieved on: 
Friday, September 29, 2023
Treasury, IRC, CSE, SAFE Banking Act, CGT, Senate, Senior, CRC, HHS, Conversion, Classification, SAFE, SAFER, Majority, Secure, TGC, Schedule, II, New Jersey Cannabis Regulatory Commission, Congress, Conditional, DEA, Investment, Gold, BID, Financial result, Transaction, Cannabis, United States Senate Committee on Banking, Housing, and Urban Affairs, Warrant (finance), Drug, Cryptocurrency, Security (finance)

As at July 31, 2023, 57% of the Company's assets was directly related to US cannabis activities.

Key Points: 
  • As at July 31, 2023, 57% of the Company's assets was directly related to US cannabis activities.
  • The Company generated $149,995 (2022 - $97,942) in interest income from its short-term treasury deposits and two receivable notes.
  • Expenses for the three months ended July 31, 2023, were $236,900 (2022 - $277,992).
  • On August 16, 2023, the Company amended and restated its definitive agreement with Cannavative (the "A&R Definitive Agreement" or the "Transaction").

Direct Digital Holdings Announces Extension of the Expiration of the Previously Commenced Offer to Purchase and Consent Solicitation Relating to its Warrants

Retrieved on: 
Thursday, September 21, 2023
Transfer, Advertising, Restatement of the Law of Agency, Third, Consent, DRCT, Marketing, Eastern Time Zone, Expiration date, Schedule, Warrant, Expiration, Colossus, Letter, Warrant (finance), Solicitation, Personal Information Agent, Security (finance), Mail, Incorporated

In order to tender the Warrants in the Offer and receive $1.20 in cash for each of their Warrants, holders of the Warrants are required to consent to the Warrant Amendment.

Key Points: 
  • In order to tender the Warrants in the Offer and receive $1.20 in cash for each of their Warrants, holders of the Warrants are required to consent to the Warrant Amendment.
  • The Company's obligation to complete the Offer is conditioned on the tender of at least 50.1% of the outstanding Warrants.
  • This announcement is for informational purposes only and shall not constitute an offer to purchase or a solicitation of an offer to sell the Warrants.
  • The Offer and Consent Solicitation are being made only through the Schedule TO and Offer to Purchase, and the complete terms and conditions of the Offer and Consent Solicitation are set forth in the Schedule TO and Offer to Purchase.

Top Strike Announces 2023 Fourth Quarter and Annual Financial Results ending April 30, 2023 and Corporate Update

Retrieved on: 
Tuesday, August 29, 2023
Treasury, CSE, CGT, CRC, Conversion, TGC, Canadian Advanced Nanospace eXperiment Program, New Jersey Cannabis Regulatory Commission, Conditional, Investment, Gold, BID, Financial result, Transaction, Warrant (finance), Cryptocurrency, Security (finance), Bank

As at April 30, 2023, 53% of the Company's assets and 92% of income was directly related to US cannabis activities.

Key Points: 
  • As at April 30, 2023, 53% of the Company's assets and 92% of income was directly related to US cannabis activities.
  • The Company generated $132,753 (2022 - $123,309) in interest income from its short-term treasury deposits and two receivable notes.
  • Expenses for the three months ended April 30, 2023, were $263,598 (2022 - $308,184).
  • On August 16, 2023, the Company amended and restated its definitive agreement with Cannavative (the "A&R Definitive Agreement" or the "Transaction").

Vencanna Announces Amended Definitive Agreement with Cannavative Group and Provides Operational Update

Retrieved on: 
Wednesday, August 16, 2023
Treasury Wine Estates, AB, MBA, Balance sheet, Cosmetic, New Jersey Cannabis Regulatory Commission, Acquisition, Investment, Patient, State University of New York, Transaction, University, Chase Bank, LEED AP, Friends, TGC, DeGroote School of Business, Plastic, Cannabis, Growth, ATC, NFP, CSE, Canadian Securities Exchange, Multichannel multipoint distribution service, Health, Beer, Business, MillerCoors, SOP, Gold, Control, Physics, CFO, Research, Hand, Family, Rotman School of Management, CGT, CRC, Theoretical physics, College of Medicine, Debenture, CSA, Sadness, University of Texas at Austin, CPA, SVKM's NMIMS, Warrant (finance), Wine, Security (finance), Sales, Crown

"Vencanna Ventures" (the "Company" or "Vencanna") (CSE: VENI) (OTCQB: TPPRF) provides the following corporate and operational updates:

Key Points: 
  • "Vencanna Ventures" (the "Company" or "Vencanna") (CSE: VENI) (OTCQB: TPPRF) provides the following corporate and operational updates:
    Effective today, the Company and The Cannavative Group LLC ("Cannavative") have amended and restated the definitive unit exchange agreement originally entered into on April 25, 2022 (as amended, the "A&R Definitive Agreement").
  • The Transaction value is US$12.5 million based on a deemed issue price of US$0.075 per Share (excluding the Earn-out Units).
  • Vencanna intends to seek shareholder approval of the Transaction by way of written resolution from shareholders holding not less than 50% plus one Share.
  • However, it is with great sadness to announce the recent passing of Mr. Ross Kline, founder, chairman, and CEO of the Cannavative Group.

Danavation Technologies Announces Financing

Retrieved on: 
Thursday, April 6, 2023
Indian stock exchange, CSE, Canadian Securities Exchange, Private, Danaveli, Susurluk, Person, Warrant, Private placement, Warrant (finance), Offering, News, Legislation, Security (finance), Unit

Toronto, Ontario--(Newsfile Corp. - April 6, 2023) - Danavation Technologies Corp. (CSE: DVN) ("Danavation" or the "Company") is pleased to announce that it intends to complete a non-brokered private placement (the "Private Placement") for gross proceeds of up to $2,000,000 through the issuance of up to 10,000,000 units (the "Units") in the capital of the Company at a price of $0.20 per Unit.

Key Points: 
  • Toronto, Ontario--(Newsfile Corp. - April 6, 2023) - Danavation Technologies Corp. (CSE: DVN) ("Danavation" or the "Company") is pleased to announce that it intends to complete a non-brokered private placement (the "Private Placement") for gross proceeds of up to $2,000,000 through the issuance of up to 10,000,000 units (the "Units") in the capital of the Company at a price of $0.20 per Unit.
  • Gross proceeds of the Private Placement will be used for working capital and general corporate purposes.
  • Mr. Harvey intends to participate in the Private Placement with a $1,000,000 investment which is expected to close on or around April 14, 2023.
  • There will be no finder fees or commissions paid in connection with the Private Placement.

Newtopia Successfully Completes 2022 Renewal Cycle and Raises $1.5M on Road to Profitability in 2023

Retrieved on: 
Wednesday, March 8, 2023
Offering, TSX Venture Exchange, Depression, Body mass index, Philosophy, Warrant (finance), DSM-IV codes, Society of Actuaries, Randomized controlled trial, Person, CDN, Health, Risk, Mental health, Anxiety, MI, Genetic testing, Habit, The Culture of the New Capitalism, Korea Disease Control and Prevention Agency, Indian stock exchange, Conditional sentence, Aetna, Human, Inspirator, Type 2 diabetes, Cryptocurrency, Marion Cotillard

The Company intends to use the net proceeds of the Offering for general corporate and working capital purposes.

Key Points: 
  • The Company intends to use the net proceeds of the Offering for general corporate and working capital purposes.
  • Contract renewals across our installed client base are a testament to the successful results delivered by our outcomes-based platform.
  • These contract renewals combined with the most recent capital raise will ultimately drive the Company toward profitability in 2023."
  • Newtopia was also recently the recipient of the highest Full-Plus recognition from the Centers for Disease Control and Prevention .

Mondee Announces Expiration and Results of Offer to Purchase and Consent Solicitation Relating to Its Warrants

Retrieved on: 
Friday, October 21, 2022
Transfer, Solicitation, Securities Act of 1933, Solution, Adoption, Warrant, LLC, Company, GLOBE, Warrant (finance), Personal Information Agent, Growth, Eastern Time Zone, Letter, Consent, Roth Capital Partners, Private, Schedule, U.S. Securities and Exchange Commission, Cayman Islands, SEC, Software as a service, IPO, Public, Form, Forward-looking statement, Security (finance), Morrow, Nasdaq

In order to tender the Warrants in the Offer and receive $0.65 in cash for each of their Warrants, holders of the Warrants were required to execute the Consent Solicitation.

Key Points: 
  • In order to tender the Warrants in the Offer and receive $0.65 in cash for each of their Warrants, holders of the Warrants were required to execute the Consent Solicitation.
  • Roth Capital Partners, LLC was the Dealer Manager for the Offer and Consent Solicitation, Morrow Sodali (Morrow) was the Information Agent for the Offer and Consent Solicitation, and Continental Stock Transfer & Trust Company was the Depositary for the Offer and Consent Solicitation.
  • This announcement is for informational purposes only and shall not constitute an offer to purchase or a solicitation of an offer to sell the Warrants.
  • The Offer and Consent Solicitation are being made only through the Schedule TO and Offer to Purchase, and the complete terms and conditions of the Offer and Consent Solicitation are set forth in the Schedule TO and Offer to Purchase.

Mondee Announces Commencement of an Offer to Purchase and Consent Solicitation Relating to its Warrants

Retrieved on: 
Friday, September 16, 2022
Transfer, Adoption, Eastern Time Zone, Expiration date, Schedule, Expiration, Roth Capital Partners, Personal Information Agent, LLC, U.S. Securities and Exchange Commission, Warrant (finance), Company, Growth, Public, Private, Forward-looking statement, Letter, Exercise, Solution, Cayman Islands, Consent, Form, GLOBE, SEC, Solicitation, Software as a service, Security (finance), Property management, Warrant, Morrow, Nasdaq

In order to tender the Warrants in the Offer and receive $0.65 in cash for each of their Warrants, holders of the Warrants are required to execute the Consent Solicitation.

Key Points: 
  • In order to tender the Warrants in the Offer and receive $0.65 in cash for each of their Warrants, holders of the Warrants are required to execute the Consent Solicitation.
  • It is the Companys obligation to complete the Offer is not conditioned on the tender of a minimum amount of Warrants.
  • This announcement is for informational purposes only and shall not constitute an offer to purchase or a solicitation of an offer to sell the Warrants.
  • The Offer and Consent Solicitation are being made only through the Schedule TO and Offer to Purchase, and the complete terms and conditions of the Offer and Consent Solicitation are set forth in the Schedule TO and Offer to Purchase.